RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, announced today that Nicholas Landekic, President & CEO of PolyMedix, will present at the New York Society of Security Analysts 14th Annual Biotech and Specialty Pharmaceutical Conference on Tuesday, November 30, 2010 at 1:35 p.m. Eastern Time.
